NLE Renal & Urinary Nursing — Renal & Urinary Assessment & DiagnosticsSummary

Each kidney contains approximately one million nephrons, the functional units responsible for urine formation. The nephron consists of the renal corpuscle (glomerulus and Bowman's capsule) where filtration occurs, and the renal tubule (proximal convoluted tubule, loop of Henle, distal convoluted tubule, and collecting duct) where selective reabsorption and secretion take place. Blood enters the glomerulus through the afferent arteriole, and about 180 liters of filtrate is produced daily; of this, approximately 1.5 liters becomes urine through selective reabsorption of water, glucose, amino acids, ions, and other useful substances, while metabolic wastes are excreted. Understanding nephron function is essential because most renal diseases affect specific segments of the tubule, producing characteristic laboratory and clinical patterns.

The kidneys perform five essential functions: (1) **Excretion of metabolic waste**: Urea (from protein metabolism) and creatinine (from muscle metabolism) are filtered at the glomerulus and normally excreted in urine. When kidney function declines, these accumulate to toxic levels. (2) **Fluid and electrolyte balance**: The kidneys regulate sodium (Na⁺), potassium (K⁺), chloride (Cl⁻), bicarbonate (HCO₃⁻), and water reabsorption/excretion to maintain osmolarity and blood volume. (3) **Acid-base balance**: The kidneys excrete hydrogen ions (H⁺) and reabsorb bicarbonate, playing a critical role in metabolic acidosis/alkalosis. (4) **Blood pressure regulation** via the renin-angiotensin-aldosterone system (RAAS): low renal perfusion triggers renin release → angiotensin II (vasoconstriction) + aldosterone (sodium/water retention) → increased blood pressure. (5) **Hormonal regulation**: The kidneys produce erythropoietin (EPO, stimulates RBC production) and activate vitamin D (enhances calcium absorption). Kidney failure results in anemia and hypocalcemia because dialysis replaces filtration but not hormone production.

Normal urine output is approximately **1–2 mL/kg/hour** or roughly **1,500 mL/day** in adults (average 1,200–1,800 mL/day). A rough clinical rule: urine output of **≥0.5 mL/kg/hour** (approximately 30 mL/hour in a 60 kg adult) indicates adequate renal perfusion. **Oliguria** is defined as urine output <400 mL/day (or <0.5 mL/kg/hour), which signals acute kidney injury or severe dehydration and requires immediate assessment. **Anuria** is virtually no urine output (<100 mL/day) and indicates severe renal dysfunction or complete urinary obstruction. **Polyuria** is excessive urine output (>2,500 mL/day) and may indicate diabetes insipidus, diabetes mellitus, or diuretic use. Accurately measuring and recording urine output is one of the nurse's most important assessments—it guides fluid management, medication dosing, and detection of acute changes in renal function.

**Normal range: 10–20 mg/dL.** BUN reflects the concentration of urea in blood, a metabolic byproduct of protein catabolism in the liver. The kidneys filter urea, so BUN rises when renal function declines. However, BUN is **non-specific** and is affected by factors other than kidney function: (1) **Dehydration/hypovolemia** increases BUN because less water is available to dilute the waste (prerenal causes). (2) **High protein intake or GI bleeding** increases protein catabolism, producing more urea. (3) **Liver disease** reduces urea production, lowering BUN. (4) **Overhydration** dilutes BUN, lowering it even if the kidney is failing. For these reasons, serum creatinine is a more specific marker of kidney function, but BUN remains useful when compared as a ratio.

**Normal serum creatinine: 0.6–1.2 mg/dL** (slightly lower in women and older adults due to reduced muscle mass; slightly higher in athletic/muscular individuals). Creatinine is produced at a constant rate from muscle creatine phosphate metabolism and is excreted almost entirely by glomerular filtration with minimal tubular reabsorption. This makes creatinine the **most specific and reliable marker of kidney function** because it is minimally affected by diet, hydration, or catabolism (unlike BUN). A rising serum creatinine indicates declining kidney function. **The BUN:creatinine ratio** (normal approximately 10:1 to 20:1) helps differentiate the *cause* of azotemia: A **high ratio (>20:1) with normal creatinine** points to a **prerenal cause** (dehydration, hypovolemia, decreased renal perfusion) because BUN rises while the kidney is still filtering creatinine adequately. A **ratio that remains normal (10:1 to 20:1) while both BUN and creatinine climb together** suggests **intrinsic renal disease** (glomerulonephritis, diabetic nephropathy) because the kidney is failing to filter both equally.

**GFR is the volume of plasma filtered by the glomeruli per minute, measured in mL/min/1.73 m² (normalized to body surface area).** Normal GFR is approximately **90–120 mL/min/1.73 m²** and represents the overall capacity of both kidneys to filter waste. GFR is the **single best overall measure of kidney function** and is used to stage chronic kidney disease (CKD). Because direct measurement of GFR requires timed urine collection and is cumbersome, **estimated GFR (eGFR)** is calculated from serum creatinine, age, sex, and body size using equations (MDRD or CKD-EPI). The five stages of CKD based on GFR are: **Stage 1 (≥90 mL/min/1.73 m²)**: Normal kidney function but with evidence of kidney damage (proteinuria, hematuria); **Stage 2 (60–89)**: Mild reduction in GFR with kidney damage; **Stage 3a (45–59)**: Moderate reduction; **Stage 3b (30–44)**: Moderate reduction; **Stage 4 (15–29)**: Severe reduction; **Stage 5 (<15)**: Kidney failure (ESRD—end-stage renal disease), typically requiring dialysis. Understanding GFR stages is critical because treatment intensity, medication dosing, and dialysis decisions are all based on GFR.

**Creatinine clearance** is a timed measure of GFR calculated as: **Creatinine clearance (mL/min) = (Urine creatinine × Urine volume in mL) / (Serum creatinine × time in minutes).** A 24-hour urine collection is the classic method: the patient discards the first morning void, then collects **ALL urine for exactly 24 hours** (starting from the next void), keeping the container **chilled or refrigerated** to prevent bacterial overgrowth and creatinine degradation. A serum creatinine is drawn during the collection period. Normal creatinine clearance is approximately **95–140 mL/min** (slightly lower in women). The advantage of measured creatinine clearance is precision; the disadvantage is the need for a complete, accurate 24-hour collection (patients often miss voids or contaminate the specimen). **Critical nursing point:** Emphasize to the patient the importance of collecting every void and keeping the container on ice. A single missed specimen invalidates the entire test and requires recollection.

As kidney function declines, the ability to regulate electrolytes is lost, leading to predictable patterns: **Potassium (K⁺, normal 3.5–5.0 mEq/L)**: The kidney excretes potassium; in renal failure, hyperkalemia develops. This is the **deadliest electrolyte disturbance in renal failure** because even mild hyperkalemia causes cardiac dysrhythmias (peaked T waves on ECG, bradycardia, asystole). Always correlate serum K⁺ with ECG findings. **Sodium (Na⁺, normal 135–145 mEq/L)**: The kidney regulates sodium; in renal failure, sodium is retained → hypernatremia, fluid retention, and hypertension. **Calcium (Ca²⁺, normal 8.5–10.5 mg/dL)**: The failing kidney cannot activate vitamin D, so calcium absorption is impaired and hypocalcemia develops. Chronic hypocalcemia triggers secondary hyperparathyroidism (the parathyroid gland overproduces PTH to drive calcium reabsorption), leading to renal bone disease. **Phosphate (PO₄³⁻, normal 2.5–4.5 mg/dL)**: The kidney excretes phosphate; in renal failure, hyperphosphatemia develops and worsens hypocalcemia (phosphate and calcium have an inverse relationship). **Bicarbonate (HCO₃⁻, normal 22–26 mEq/L)**: The kidney reabsorbs bicarbonate and excretes H⁺; in renal failure, metabolic acidosis develops (low pH, low HCO₃⁻).

Urinalysis is the single most useful, low-cost diagnostic test for renal and urinary disease. It provides immediate information about urine composition and quality. **Normal findings:** **Color**: Pale yellow to amber (varies with hydration; concentrated urine is darker); abnormal colors suggest pathology (cola/tea-colored → hematuria or myoglobin from rhabdomyolysis; cloudy → infection or crystals; dark brown → hemolysis or liver disease). **pH**: Normal is approximately 4.5–8.0 (average ~6); acidic urine may indicate urinary tract infections (certain bacteria prefer alkaline urine) or metabolic acidosis; alkaline urine may indicate respiratory alkalosis or urinary tract infections with urease-producing organisms. **Specific gravity**: Normal range 1.005–1.030 reflects urine concentration; **high specific gravity (>1.030) indicates concentrated urine (dehydration, excessive sweating)**; **low specific gravity (<1.005) indicates dilute urine (overhydration, diabetes insipidus)**; **fixed low specific gravity (~1.010) in renal failure indicates loss of concentrating ability**, a hallmark of kidney disease. **Protein**: Normally negative or trace; proteinuria (>150 mg/day) signals glomerular damage, nephrotic syndrome, or diabetic nephropathy. **Glucose**: Normally negative (glucose is filtered but reabsorbed in the proximal tubule); glycosuria appears when blood glucose exceeds the renal threshold (~180 mg/dL), suggesting diabetes mellitus or tubular dysfunction. **Ketones**: Normally negative; ketonuria suggests starvation, diabetic ketoacidosis, or intense exercise. **Blood/RBCs**: Normally negative; hematuria suggests stones, infection, glomerulonephritis, trauma, or tumor. **RBC casts**: Indicate glomerulonephritis (RBCs trapped in casts during tubular passage). **WBCs/leukocyte esterase/nitrites**: Suggest urinary tract infection (leukocyte esterase and nitrites are more specific for bacteria). **WBC casts**: Indicate pyelonephritis (infection of the kidney/renal pelvis). A **clean-catch midstream specimen** is standard for routine urinalysis; a **first-morning specimen** is preferred for cytology because it is most concentrated.

**Urine culture and sensitivity (C&S)** is the gold standard for diagnosing urinary tract infection (UTI) and determining the causative organism and its antibiotic susceptibilities. The culture identifies the specific bacterium (E. coli, Klebsiella, Staphylococcus saprophyticus, etc.) and **sensitivity testing determines which antibiotics are effective** against that organism, guiding antibiotic selection. A **positive culture** is typically ≥100,000 CFU/mL (colony-forming units) in a clean-catch specimen or ≥10,000–100,000 CFU/mL in a straight catheterized specimen. **Critical nursing responsibility:** Obtain the urine specimen **before initiating antibiotics** so that bacterial growth is not suppressed and the organism can be cultured. Use a **sterile container** and ensure the patient understands clean-catch technique (for women: clean the perineum front-to-back, discard the first stream, then collect midstream; for men: retract the foreskin if uncircumcised, clean the meatus, discard the first stream, then collect midstream). In Philippine settings where UTIs are common, ensuring proper specimen collection and sending samples to the laboratory promptly (without delay) is essential for accurate diagnosis and preventing unnecessary broad-spectrum antibiotic use.

Several imaging and endoscopic procedures assess renal and urinary anatomy and function: **KUB (kidney-ureter-bladder) X-ray)**: A plain radiograph showing the bony pelvis and kidneys; useful for detecting radiopaque stones (calcium oxalate) and assessing renal size. Requires no special preparation. **Renal ultrasound**: Uses sound waves to visualize kidney structure, size, parenchymal thickness, presence of masses/cysts, and obstruction. No radiation, no contrast, no fasting required—excellent for renal screening and differentiation of acute vs. chronic kidney disease (chronic disease shows small, echogenic kidneys). **Intravenous pyelogram (IVP) or urography**: Contrast dye injected intravenously to visualize the urinary tract over time; useful for detecting obstruction, stones, and structural abnormalities. **Nursing considerations for IVP:** (1) Assess for **iodine allergy and shellfish allergy** (contrast contains iodine)—report to the radiologist; (2) Check **baseline renal function (BUN and creatinine)** before contrast (contrast can cause contrast-induced nephropathy, especially in patients with pre-existing renal disease, diabetes, or dehydration); (3) **Ensure adequate hydration** before and after the procedure; (4) **Hold metformin** around the procedure (metformin + contrast + renal impairment increases risk of lactic acidosis); (5) Bowel prep may be ordered (cathartics, NPO) to clear the colon for clearer images; (6) **Push fluids after the procedure** to flush the contrast dye through the kidneys and prevent acute kidney injury. **Cystoscopy**: Direct visualization of the bladder and urethra using a cystoscope; allows biopsy, stone removal, or treatment of bleeding. **Post-cystoscopy nursing:** Expect **pink-tinged urine for 24 hours** (normal irritation); provide warm sitz baths and encourage fluids; report **bright-red bleeding, clots, inability to void, fever, or severe pain** (signs of perforation or infection). **Renal biopsy**: A needle is percutaneously inserted into the kidney to obtain tissue for microscopic examination, diagnosing glomerulonephritis, lupus nephritis, and other parenchymal diseases. **Post-biopsy nursing:** The kidney is highly vascular—**maintain bed rest** to minimize bleeding, **monitor vital signs** closely, observe for **hematuria, flank pain, and signs of shock**, avoid strenuous activity/heavy lifting for 2 weeks, and report any bleeding immediately.

Indications for catheterization include relief of urinary retention, accurate measurement of urine output in critically ill patients, and management of incontinence. However, each day a catheter remains in situ increases UTI risk—**catheter-associated urinary tract infection (CAUTI)** is among the most common healthcare-associated infections in the Philippines and worldwide. **Insertion technique:** Use **strict aseptic (sterile) technique**: sterile gloves, sterile field, sterile catheter, and antiseptic cleansing of the urethral meatus. Proper technique reduces infection risk. **Catheter maintenance:** (1) **Keep the drainage bag BELOW the level of the bladder at all times**—gravity prevents urine from backing up into the bladder (reflux), which would introduce bacteria. Never rest the bag on the floor (contamination risk). (2) **Maintain a closed system**—do not disconnect the catheter from the tubing or the tubing from the bag unless absolutely necessary; each disconnection introduces bacteria. (3) **Secure the catheter** to the inner thigh (in women) or lower abdomen (in men) to prevent movement and urethral trauma; movement also increases infection risk. (4) **Avoid dependent loops** in the tubing—coils of tubing create reservoirs for bacteria. (5) **Provide routine perineal care** daily and after bowel movements using soap and water (not antiseptics, which are not more effective). (6) **Ensure adequate fluid intake** to maintain dilute urine, which reduces bacterial colonization. (7) **Remove the catheter as soon as clinically possible**—every day of catheterization increases CAUTI risk exponentially. Document the indication for catheterization and regularly assess whether it is still necessary. **Drainage after acute retention:** After relieving acute urinary retention (from obstruction, enlarged prostate, or neurogenic bladder), some guidelines suggest **gradually draining the bladder over time** rather than rapid complete drainage (to avoid hematuria, hypotension from sudden fluid shift, and bladder shock). Institutional policy varies; typically, drain 500–800 mL initially, clamp for 15–30 minutes, then drain again, repeating until empty over 1–2 hours. **Difficulty with insertion:** Never force a catheter against resistance—resistance suggests a stricture, enlarged prostate (in men), or anatomical obstruction. Document the difficulty, notify the provider, and consider a smaller catheter or specialty insertion techniques.

Dialysis is an artificial process that substitutes for lost kidney function by removing excess fluid, electrolytes, and uremic wastes from the blood. Two physical principles drive the process: **(1) Diffusion**: Solutes (urea, creatinine, potassium, phosphate) exist at high concentrations in the patient's blood and low concentrations in the dialysate (dialysis fluid). Across a semipermeable membrane, solutes move down their concentration gradient *from blood into the dialysate*, where they are discarded. This removes uremic wastes. **(2) Osmosis/Ultrafiltration**: Water moves across the membrane in response to osmotic or hydrostatic pressure gradients. In peritoneal dialysis, dextrose (glucose) in the dialysate creates an osmotic gradient that pulls excess water from the blood into the peritoneal cavity. In hemodialysis, a pressure gradient (ultrafiltration pressure) generated by the dialysis machine pulls water out. This removes excess fluid accumulated from drinking and impaired renal excretion. **Dialysate composition** is critical: it is a **balanced electrolyte solution containing sodium, potassium (low or absent), calcium, magnesium, chloride, bicarbonate, and dextrose, warmed to body temperature (37°C)**. The dialysate contains **no urea and no creatinine** (or only trace amounts) so these wastes diffuse out of the blood. **Key nursing insight**: Dialysis is a mechanical filtration process; it **does NOT restore the kidney's hormonal functions**. Patients on dialysis still require **erythropoietin (EPO) injections** to manage anemia, **active vitamin D supplementation** to manage hypocalcemia and renal bone disease, and **phosphate binders** to manage hyperphosphatemia. Dialysis removes the solutes but not the hormone deficiency.

A comprehensive renal nursing assessment begins with a focused history and physical examination. **History questions:** Ask about **changes in voiding patterns**: frequency (polyuria vs. oliguria), urgency, hesitancy (difficulty initiating stream), nocturia (nighttime urination—often early sign of renal disease), incontinence, and retention (inability to empty bladder). Ask about **urine appearance**: color (pale vs. dark vs. cola-colored), odor (strong/foul suggests infection), clarity (cloudy suggests infection or crystals), and presence of **hematuria** (visible blood in urine). Ask about **fluid intake**: daily consumption of water, caffeine, alcohol. Ask about **pain**: flank pain (kidney/stone), suprapubic pain (bladder), dysuria (urethral/bladder irritation). Ask about **weight changes and edema**, which indicate fluid status. Ask about **systemic symptoms**: fever (infection), nausea/vomiting (uremia), fatigue (anemia or uremia). Ask about **medication history—especially nephrotoxic drugs**: aminoglycosides (gentamicin, tobramycin), NSAIDs (ibuprofen, naproxen), ACE inhibitors/ARBs (risk in certain settings), contrast dye, and some antibiotics. Ask about **past medical history**: hypertension, diabetes, recurrent UTIs, kidney stones, family history of kidney disease. **Physical examination:** **Weight and vital signs:** Daily weight at the same time, on the same scale, with the same clothing is the **single most reliable indicator of fluid gain/loss**; remember that **1 kg ≈ 1 L of fluid**. Calculate whether the patient has gained or lost weight since the last assessment. Check **blood pressure** (hypertension in renal disease from fluid retention and RAAS activation). **Fluid status assessment:** Inspect for **edema**—periorbital edema (eyes puffed in the morning) suggests fluid overload; dependent edema (ankles, feet, sacrum in bedbound patients) indicates sodium/water retention. Auscultate **lung sounds** for crackles (rales), which indicate pulmonary edema from fluid overload. Assess **jugular venous distension (JVD)**—distended neck veins indicate elevated central venous pressure from volume overload. **Skin:** Note **pallor** (anemia from EPO deficiency), **dryness** (uremia), and **uremic frost** (white powder on skin from crystallized uremic toxins—a sign of severe, untreated uremia). **Abdomen/flank:** Gently palpate the abdomen and assess for a **distended bladder** (palpable/percussable suprapubically above the symphysis pubis); a distended bladder indicates retention. Assess **costovertebral angle (CVA) tenderness** by gently percussing the flanks (over the kidneys)—tenderness suggests pyelonephritis (kidney infection) or nephrolithiasis (kidney stones).

As kidney function declines, the renal diet becomes increasingly restrictive because the kidney loses its ability to excrete certain substances and regulate electrolytes. Understanding the renal diet is essential because improper nutrition exacerbates uremia, hyperkalemia, hypertension, and renal bone disease. **Sodium restriction:** The failing kidney cannot excrete sodium effectively; sodium retention → fluid retention (edema, hypertension, pulmonary edema) and worsening of the RAAS. Typical restriction is **<2 g/day (goal <1 g/day in advanced CKD)**, which requires patient education about avoiding processed foods, canned foods, added salt, and condiments like soy sauce (common in Filipino cuisine), fish sauce, and shrimp paste. **Potassium restriction:** As GFR falls, potassium excretion declines and hyperkalemia develops—hyperkalemia is life-threatening (ECG changes, cardiac arrhythmias, cardiac arrest). **Avoid high-potassium foods**: bananas, oranges, tomatoes, potatoes, spinach, legumes (beans, peas), coconut water (high K⁺), salt substitutes (contain potassium chloride). Patients on dialysis may tolerate more potassium because dialysis removes potassium; pre-dialysis patients must restrict. **Phosphate restriction and phosphate binders:** The failing kidney cannot excrete phosphate; hyperphosphatemia develops and drives secondary hyperparathyroidism (PTH overproduction → renal bone disease). **Phosphate-binding medications** (calcium carbonate, sevelamer, calcium acetate) are taken **with meals** to bind dietary phosphate and reduce absorption; the binders must be taken at mealtimes or they are ineffective. **Protein management:** Pre-dialysis, a **low-protein diet** (0.6–0.8 g/kg/day) reduces the nitrogen load and slows uremic toxin accumulation—this was historically used to delay dialysis initiation (though evidence is mixed). Post-dialysis, protein is often **increased** (1.0–1.2 g/kg/day) because dialysis removes amino acids; adequate protein prevents malnutrition and muscle wasting. **Fluid restriction:** As GFR falls, fluid excretion declines. Fluid restriction is individualized based on **urine output plus insensible losses** (respiration, perspiration). A rough formula: **allowed fluid = 24-hour urine output + 500–1,000 mL** (insensible loss). In oliguric/anuric patients, fluid may be restricted to 500–800 mL/day to prevent overload. **Calorie intake:** Ensure adequate calories (30–35 kcal/kg/day) to prevent catabolism and muscle wasting, often using carbohydrates and fats.

Across all renal conditions, certain nursing diagnoses recur. Using **NANDA-I nursing diagnoses** and **Maslow's hierarchy of needs**, nurses prioritize care as follows. **Physiological needs (highest priority—base of Maslow's pyramid):** **Fluid volume imbalance (excess or deficit)** — excess occurs with oliguria (kidney cannot excrete fluid) causing edema, hypertension, crackles, pulmonary edema, and weight gain; deficit occurs with polyuria (excessive fluid loss) causing dehydration, hypotension, and dry mucous membranes. Daily weight and I&O are the core monitoring tools. **Electrolyte imbalance — particularly risk for hyperkalemia** — the most life-threatening complication of renal failure; correlate serum K⁺ with ECG findings (peaked T waves, widened QRS, loss of P waves). **Risk for infection** — from urinary catheters (CAUTI), vascular access (fistula/graft infections), and immunosuppression in transplant patients; strict asepsis is essential. **Impaired skin integrity** — from edema, uremic pruritus (intense itching from uremic toxins), immobility, and poor nutrition; maintain skin care, apply emollients, prevent pressure ulcers. **Safety needs:** **Risk for injury** — from hypertension, anemia (fatigue, falls), medication effects, and electrolyte disturbances. **Belonging/Love needs:** **Social isolation** — dialysis patients may feel isolated due to time spent on treatment and dietary/fluid restrictions; encourage peer support and involvement of family. **Esteem needs:** **Disturbed body image** — vascular access (fistula, graft), dependent on machine/treatment, may feel loss of independence. **Self-actualization:** **Knowledge deficit** — diet, fluid limits, medication timing/renally dosing, catheter care, access care, when to seek help. **Common nursing diagnoses in renal patients (NANDA-I):** Fluid volume excess r/t compromised regulatory mechanism (kidney failure) m/b edema, hypertension, weight gain; **Fluid volume deficit r/t excessive fluid loss (polyuria) m/b dehydration, hypotension**; **Risk for hyperkalemia r/t kidney failure**; **Risk for infection r/t urinary catheter/vascular access**; **Impaired skin integrity r/t edema, uremia, immobility**; **Ineffective renal perfusion r/t hypovolemia, sepsis, vasodilation**; **Deficient knowledge** regarding diet, medications, disease management.

Older adults experience a normal, age-related decline in kidney function—**GFR declines approximately 10 mL/min/1.73 m² per decade after age 30, even in the absence of kidney disease**. This physiological change has profound clinical implications: (1) **Reduced drug clearance**: Many medications are renally cleared; in older adults with reduced GFR, drug accumulation occurs and toxicity risk increases. Medications must be **renally dosed**—the dose or interval adjusted based on GFR. Examples include aminoglycosides (risk of ototoxicity and nephrotoxicity), NSAIDs (risk of acute kidney injury), and ACE inhibitors (hyperkalemia risk). (2) **Reduced concentrating ability**: Older kidneys are less able to concentrate urine, so older adults **dehydrate easily**, especially in hot weather, during illness, or with diuretic use. They are at high risk for **prerenal acute kidney injury** triggered by dehydration. (3) **Hyperkalemia risk**: Older adults on ACE inhibitors or ARBs (common for hypertension/diabetes) are at increased risk of **hyperkalemia**, a life-threatening complication. (4) **Urinary symptoms**: Nocturia is common and often attributed to aging rather than investigated for underlying pathology (enlarged prostate, diabetes, sleep apnea). (5) **UTI presentation**: Older adults may not present with classic dysuria/frequency; instead, they may have **confusion, delirium, or nonspecific symptoms**, delaying diagnosis. **Nursing implications:** Assess volume status carefully in older adults; ensure adequate hydration but avoid overload; monitor renal function closely when initiating medications; educate about medication timing relative to meals (some drugs require specific timing); monitor for signs of dehydration (dry mucous membranes, poor skin turgor, orthostatic hypotension); assess for UTI symptoms (behavioral changes, confusion) not just dysuria.

Delivering culturally competent renal nursing in the Philippine context requires awareness of several factors: (1) **Dietary practices**: Filipino diet often includes high-sodium foods (preserved fish, salted eggs, shrimp paste/bagoong, fish sauce/patis, soy sauce, cured meats), high-potassium coconut water (a traditional remedy), and reliance on rice and starches. Education about lower-sodium preparations and alternatives is essential. (2) **Traditional and herbal remedies**: Some Filipinos use traditional remedies for kidney and urinary complaints; some herbs are nephrotoxic or interact with medications. Respectfully ask about herbal use and, if indicated, explain safety concerns. (3) **Family involvement in healthcare**: The extended family is often involved in healthcare decision-making. Education and counseling should include family members; they influence dietary adherence and medication compliance. (4) **Economic constraints**: Many Filipino patients have limited access to dialysis, transplantation, and expensive medications. Nurses must work within these realities, emphasize conservative management and preventive care, and advocate for equitable access to care. (5) **Limited laboratory access in rural settings**: In provincial and rural Philippines, advanced diagnostics may not be available. Nurses must be skilled at clinical assessment (physical examination, observation, vital signs) when laboratory confirmation is delayed. (6) **Medication availability**: Certain medications may be unavailable or unaffordable; nurses must work with patients and providers to find feasible alternatives. (7) **Health literacy**: Health education must be delivered in simple, clear language (Tagalog or local dialect) with visual aids and return-demonstration to ensure understanding.